Invitrogen™ IL-1 beta Mouse ELISA Kit

Ref.: BL-RE-171992Manufacturer ref.: BMS6002-2 96 Tests
€714.00 excl. VAT

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol.…

Accession number
P10749
Dose range
7.8 to 500
Sensitivity of the dosage
1.2 pg/mL
Conjugate
HRP
Product type
ELISA
Brand
Invitrogen

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol.…

Interleukin-1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol. Cleavage of pro-IL-1 beta into the active 17 kDa protein requires the activation of inflammasomes, which are multi-protein complexes that respond to pathogens, stress conditions, and other danger signals. Inflammasome activation triggers the processing of the caspase-1 precursor into its active form, which in turn cleaves pro-IL-1 beta. IL-1 beta lacks a signal sequence peptide for classical ER/Golgi pathway and is secreted alongside caspase-1 via an alternate and incompletely understood mechanism. Although IL-1 beta is most often secreted in its active form, secretion of the uncleaved protein may be detectable under some biological conditions. IL-1 beta signals through two receptors, IL-1RI and IL-1RII, both of which are shared with IL-1 alpha. IL-1 beta activity can be moderated by IL-1 Receptor Antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding through competitive inhibition. IL-1 beta play an important role in innate host defense by triggering the production of other proinflammatory cytokines in target cells and initiating acute-phase responses to infection and injury. Elevated levels of IL-1 beta have been associated with many chronic inflammatory conditions IL-1 beta neutralizing antibodies potential therapeutic value.

Sensitivity

Sensitivity of the dosage: 1.2 pg/mL.

Measurement range

Dose range: 7.8 to 500.

Duration of dosing

Total duration of dosing: 3 h 10 min.

Reproducibility

Coefficient of variation in intra-dose 5.1%, inter-dose 5.7%.

Samples

Sample type: Serum (volume 50 µL).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)18061673
Specifications
Accession numberP10749
Dose range7.8 to 500
Sensitivity of the dosage1.2 pg/mL
ConjugateHRP
Product typeELISA
Type of sampleSerum
For use with (equipment)Colorimetric Microplate Reader
Genetic identification (Enter)16176
Gene symbol(s)IL1B
Coefficient of inter-dose variation5.7%
Coefficient of intra-dose variation5.1%
Contents of kitsPre-coated 96 well flat, Standard, Sample Dilute, Assay Buffer Concentrate, Biotinylated Detection Antibody, SAV-HRP, Wash Buffer, Chromogen, Stop Solution, Adhesive Plate Covers
Marker or dyeHRP
Quantity96 Tests
Regulatory statusRUO
TargetMouse
Test time1 hr 20 min
Physical characteristics
Volume of sample50 µL
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing3 hr 10 min

Origin and customs

Manufacturer ref.BMS6002-2
Country of originAutriche
HS customs code3822 11 00 00
A question or a specific configuration?
Contact us for a quote.